HeartSciences Inc.HSCSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +738.70% | +83.31% | +64.60% | +67.60% | +203.07% |
| Weighted Average Shares Diluted Growth | +738.70% | +83.31% | +64.60% | +67.60% | +203.07% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | -3.25% | -2.70% | +3.35% | +1.01% | +0.67% |
| Asset Growth | +228.38% | -47.19% | -55.56% | -21.42% | -22.90% |
| Book Value per Share Growth | +0.00% | -88.71% | -98.30% | -68.42% | -65.64% |
| Debt Growth | +45.27% | +182.02% | +188.05% | +92.35% | -69.82% |
| R&D Expense Growth | +58.32% | +102.77% | -11.19% | -18.59% | -39.36% |
| SG&A Expenses Growth | -6.90% | +30.92% | +16.74% | +7.42% | +74.99% |